REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol

REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol

Abstract Objective Long-term oxygen therapy (LTOT) during 15 h/day or more prolongs survival in patients with chronic obstructive pulmonary disease (COPD) and severe hypoxemia. No randomized controlled trial has evaluated the net effects (benefits or harms) from LTOT 24 h/day compared with 15 h/day...

Full description

Bibliographic Details
Main Authors: Josefin Sundh, Anna Bornefalk-Hermansson, Zainab Ahmadi, Anders Blomberg, Christer Janson, David C. Currow, Christine F. McDonald, Nikki McCaffrey, Magnus Ekström
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Pulmonary Medicine
Subjects:
Register-based randomized controlled trial
Hypoxaemia
Long-term oxygen therapy
Oxygen duration
Chronic obstructive pulmonary disease
Interstitial lung disease
Online Access:http://link.springer.com/article/10.1186/s12890-019-0809-7

Internet

http://link.springer.com/article/10.1186/s12890-019-0809-7

Similar Items